ELEVEN BIOTHERAPEUTICS INC's ticker is EBIO and the CUSIP is 286221106. A total of 26 filers reported holding ELEVEN BIOTHERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $59,000 | +31.1% | 56,222 | 0.0% | 0.00% | – |
| Q4 2017 | $45,000 | -48.9% | 56,222 | 0.0% | 0.00% | – |
| Q3 2017 | $88,000 | 0.0% | 56,222 | 0.0% | 0.00% | – |
| Q2 2017 | $88,000 | -14.6% | 56,222 | +19.1% | 0.00% | – |
| Q1 2017 | $103,000 | +15.7% | 47,187 | +0.6% | 0.00% | – |
| Q4 2016 | $89,000 | -31.5% | 46,887 | +0.4% | 0.00% | – |
| Q3 2016 | $130,000 | +68.8% | 46,687 | +0.1% | 0.00% | – |
| Q2 2016 | $77,000 | +450.0% | 46,637 | 0.0% | 0.00% | – |
| Q1 2016 | $14,000 | -90.0% | 46,637 | -0.1% | 0.00% | – |
| Q4 2015 | $140,000 | +25.0% | 46,687 | +0.2% | 0.00% | – |
| Q3 2015 | $112,000 | -14.5% | 46,587 | +0.2% | 0.00% | – |
| Q2 2015 | $131,000 | -62.4% | 46,487 | +18.8% | 0.00% | – |
| Q1 2015 | $348,000 | -5.2% | 39,125 | +26.4% | 0.00% | – |
| Q4 2014 | $367,000 | +7.0% | 30,960 | +0.5% | 0.00% | – |
| Q3 2014 | $343,000 | +9.6% | 30,810 | +29.5% | 0.00% | – |
| Q2 2014 | $313,000 | -10.6% | 23,791 | +10.1% | 0.00% | – |
| Q1 2014 | $350,000 | – | 21,617 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|